Notice of Intent to Sole Source.pdf

Notice of Intent to Sole Source

Subject: Fixed Price (FFP) Purchase Order Type for the procurement of a CDER-2023-118721 ss ChemiDOC MP Imaging System, Sole Source, under Request for Quote FDA-RFQ-CDER-2023- 118721.

Notice of Intent to Sole Source to: Bio-Rad Inc.

Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, (there is only one responsible source, and no other supplies or services will satisfy agency requirements). The Food and Drug Administration (FDA) intends to award a Sole Source Fixed Price (FFP) Purchase Order Type to Bio-Rad Inc., located at:

ATTN: Nathan Andrews Bio-Rad Inc 2000 Alfred Nobel Drive, Hercules, CA 94547 Tel: 1-800-4-BIORAD nathan_andrews@bio-rad.com Email americas@bio-rad.com

FDA requires a CDER-2023-118721 ss ChemiDOC MP Imaging System, Sole Source, under Request for Quote FDA-RFQ-CDER-2023-118721. This is a request for the procurement of a ChemiDOC MP Imaging System, and the instrument is solely distributed by the manufacturer/subsidiaries and official distributors, with no thirty party re-sellers. The proposed acquisition is to procure a ChemiDocTM MP Imaging System/image analyzer for the assessment of DNA and protein-based biochemical and cell biological techniques to support ongoing research of OBP Bioassay Initiative. Bio-Rad Inc., is the sole manufacturer of the system, and no market equivalents exist. Thermo Fisher Scientific-https://www.thermofisher.com/order/catalog/product/ A44241. Bioimager-https://www.bioimager.com/product/chemlux-600-chemiluminescent -gel-blot-imager-with-fluorescent-luminescent-colorimetric-imaging/, and Azure Biosystems- https://azurebiosystems.com/sapphirefl/.

The requested instrument is solely distributed by the manufacturer/subsidiaries and official distributors, with no thirty party re-sellers.

The associated NAICS Code is: 334516-Analytical Laboratory Instrument Manufacturing. Offerors must have an active registration in www.SAM.gov, with completed representations and certifications, by the close date of the solicitation.

This notice is not a request for competitive proposals. However, any party that believes it is capable of meeting this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement. Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.

It is anticipated that an award will be issued to Bio Rad Inc., within approximately fifteen (15) days after the date of this notice unless the Government determines that any other organization has the capacity to meet this requirement.

Response Date: 12:00 p.m. EST 06/15/2023. Please email responses to Emmanuel Mbah at Emmanuel.mbah@fda.hhs.gov mailto:Emmanuel.mbah@fda.hhs.gov